These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Roche submits NDA for Invirase. J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796 [TBL] [Abstract][Full Text] [Related]
4. Saquinavir plus ddC reduces deaths by more than two-thirds. J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363697 [TBL] [Abstract][Full Text] [Related]
5. Potent new AIDS drugs underscore promise of combination therapy. AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225 [TBL] [Abstract][Full Text] [Related]
6. A kinder, gentler ddC... for $7,200 a year. GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362996 [TBL] [Abstract][Full Text] [Related]
7. No tease this time--pros and cons of a long-awaited anti-HIV drug. Chang HE Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118 [TBL] [Abstract][Full Text] [Related]
8. Protease inhibitor trials moving to next phase. AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675 [TBL] [Abstract][Full Text] [Related]
9. Update on HIV protease inhibitors. Vella S AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832 [TBL] [Abstract][Full Text] [Related]
10. Protease inhibitors and prevention of cross resistance. Levin J AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875 [TBL] [Abstract][Full Text] [Related]
11. Ritonavir: first to prolong survival. MacDougall DS J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517 [TBL] [Abstract][Full Text] [Related]